GAB2 and obesity disorder: However, Gab2 was found to be recruited by a variety of pathogenic factors to initiate the pathogenesis of hepatitis, fatty liver, and obesity by mediating a variety of signaling molecules, thus promoting the occurrence and development of liver cancer [9,10,11].